CordenPharma

CordenPharma is a leading Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs), peptide manufacturing, lipid technologies, excipients, and finished dosage forms. Established in 2006 and headquartered in Basel, Switzerland, the company has built a strong international reputation for supporting pharmaceutical and biotechnology companies with integrated development and commercial manufacturing services.

CordenPharma is particularly recognized for its expertise in complex APIs, highly potent active pharmaceutical ingredients (HPAPIs), peptide APIs, oligonucleotides, lipid excipients, and advanced pharmaceutical technologies. The company has played a significant role in supporting innovative therapies, including lipid systems used in mRNA-based medicines. Its experienced scientific teams provide process development, analytical services, scale-up, technology transfer, and commercial manufacturing across the pharmaceutical product lifecycle.

With manufacturing and research facilities across Europe and North America, CordenPharma operates under rigorous international quality standards while maintaining strong compliance with global regulatory agencies. The company continuously invests in sustainability, digital manufacturing, advanced production technologies, and scientific innovation to meet evolving pharmaceutical industry needs. Through long-term customer partnerships and technical excellence, CordenPharma has become one of the world’s most respected manufacturers of complex pharmaceutical ingredients and specialty APIs.